Creating a laboratory to prevent cancer through immunotherapy.
Official title: DCP- Cancer Immunoprevention Laboratory Support
Funded at Leidos Biomedical Research, INC. · NIH-11219782 · Data updated 2026-11-12
This study is setting up a new lab to find better ways to use the immune system to help prevent cancer, and it aims to create helpful strategies that could benefit patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 28, 2024 |
| Project end | August 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $3,163,335 |
| NIH project number | 75N91019D00024-0-759102400011-19 |
| Project ID | NIH-11219782 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for developing cancer or those interested in preventive measures against malignancies.
✕Less likely to help
Patients with existing cancer diagnoses may not receive direct benefits from this research focused on prevention.
What this research studies
This research aims to establish a new Cancer Immunoprevention Laboratory dedicated to advancing methods that help prevent cancer through immunotherapy. The laboratory will serve as a reference facility, confirming results from various contractors and ensuring standardized methods are used in the development of immunoprevention strategies. By focusing on preclinical development, the laboratory will work on innovative concepts that could lead to effective cancer prevention techniques. Patients may benefit from the advancements made in understanding how to harness the immune system to prevent cancer.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing cancer, potentially reducing the incidence of malignant tumors.
How similar studies have gone: Other research in cancer immunoprevention has shown promise, indicating that this approach could lead to significant advancements in cancer prevention strategies.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.